Why another biomedical journal? With the thousands of new journals launched each year, what new does “Atlas Journal of Medical and Biological Sciences” bring to scientific discourse? This is the same opening that meets every journal before it builds its own identity. Ours will, as other journals we edit, be characterized by openness for new ideas that have solid supporting documentation. Scientific advance requires dissemination of ideas that will advance scholarly inquiry and contrast with the many journals that focus on incremental advance of accepted dogma. This is an incredibly exciting period in biology-medicine, post genomic and soon to be post proteomic. After over half a century of dominance, reductionism is failing to assist in our understanding of disease. This is a period when by returning to basics of biology we have a chance to make major advances. Through your support, AJMBS will play a role in that transformation.
Bharat B. Aggarwal, Onur Bender, Tarun Belwal, Ihosvany Camps, Carlos L. Céspedes, Alessandra Cincinelli, Ricardo Diego D.G. de Albuquerque, Claudio Ferrante, Mohammad Amjad Kamal, Shafi Ullah Khan, In Ho Kim, Manoj G. Kulkarni, Haipeng Lv, Si Mi, Andrei Mocan, Adriano Mollica, A.R. Ndhlala, Vince Ördög, Jelena Popović‐Djordjević, Jaruporn Rakmai, Visweswara Rao Pasupuleti, Satyajit D. Sarker, Barbara Sawicka, Gautam Sethi, A. Sanches‐Silva, Karel Šmejkal, Hafiz Ansar Rasul Suleria, Michał Tomczyk, Chunpeng Wan, Dongdong Wang, Ren Wang, Zhao‐Jun Wei, Jianbo Xiao, Jialin Xu, Zhi‐Ling Yu, Gökhan Zengin, Jesus Simal Gandara
Giuseppe Biondi‐Zoccai, Attilio Lauretti, Stefan Agewall, Emmanuel Andrès, Riccardo A. Audisio, Deepak L. Bhatt, Giuseppe Citerio, Jonathan A. Drezner, Alexander M.M. Eggermont, Çetin Erol, Karen D. Ersche, Giorgio Ferriero, Gerd Heusch, Ciro Indolfi, Paul A. Insel, Carl J. Lavie, Carlo La Vecchia, Nicola Maffulli, Fabrizio Montecucco, David J. Moliterno, Stanley Nattel, Peter O’Kane, E Oliaro,
Discussion(0)
No comments yet. Be the first to comment.